Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.
Fiorentini, G
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study. [electronic resource] - Journal of chemotherapy (Florence, Italy) Nov 2004 - 51-4 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
1120-009X
10.1080/1120009x.2004.11782385 doi
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Colorectal Neoplasms--pathology
Epirubicin--administration & dosage
Filtration
Humans
Infusions, Intra-Arterial--methods
Liver Neoplasms--drug therapy
Mitomycin--administration & dosage
Prospective Studies
Survival Rate
Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study. [electronic resource] - Journal of chemotherapy (Florence, Italy) Nov 2004 - 51-4 p. digital
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
1120-009X
10.1080/1120009x.2004.11782385 doi
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Colorectal Neoplasms--pathology
Epirubicin--administration & dosage
Filtration
Humans
Infusions, Intra-Arterial--methods
Liver Neoplasms--drug therapy
Mitomycin--administration & dosage
Prospective Studies
Survival Rate